1. Abrams WB, Pocelinko R, Klausner M, Hanauer L, Whitman EN (1964) Clinical pharmacological studies with debrisoquin sulfate, a new antihypertensive agent. J New Drugs 4: 268?283
2. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. APA task force on nomenclature and statistics, Washington, DC
3. Bacopoulos NG, Hattox SE, Roth RH (1979) 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indications of central dopaminergic activity. Eur J Pharmacol 56: 225?236
4. Baldessarini RJ, Tracy D (1978) Tardive dyskinesia. In: Lipton MA, DiMascio A, Killian KP (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 993?1004
5. Berger PA, Faull KF, Kilkowski J, Anderson PJ, Kraemer H, Davis K, Barchas JD (1980) CSF monoamine metabolites in depression and schizophrenia. Am J Psychiat 237: 174?180